GlaxoSmithKline News

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Just as major drugmakers such as GlaxoSmithKline express more interest in traditional Chinese medicine , some practices are generating sustained protests.

Scientists from GlaxoSmithKline are to study how traditional Chinese medicine can be applied to modern drugs as part of a revamp of the company's research and development.

Last week, we got to hear from Sir Andrew Witty , CEO of GlaxoSmithKline . The talk was part of the Pears Business Schools Partnership Lecture, which promotes sustainable and responsible business through inspiring future leaders.

Each week, a professional investor tells MoneyWeek where he'd put his money now.

Three years after overhauling its R&D engine, GlaxoSmithKline last week provided investors a glimpse at the results of its new, biotech-like approach to research.

The Fed's promise of low interest rates is exciting news to both investors and companies.

Stevenage, UK, February 9 2012 - Stevenage Bioscience Catalyst , the UK's first open innovation bioscience campus, is pleased to announce that it is now open for business.

The Deal : Oracle announced Thursday that it has entered into an agreement to acquire Taleo Corporation for $46.00 per share or approximately $1.9 billion, net of Taleo's cash and debt.

Vodafone Group Plc is moving cash from Greece into the U.K. "every evening" and could bill in a different currency, mirroring efforts by GlaxoSmithKline Plc, WPP Plc and Reckitt Benckiser Group Plc to hedge against the European debt crisis.

GlaxoSmithKline 's stock had its "neutral" rating reiterated by Zacks Investment Research in a research report issued to clients and investors on Thursday.

GSK is bringing outsourced work back in-house and placing manufacturing at existing sites in a bid to boost efficiency.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia GSK is bringing outsourced work back in-house and placing manufacturing at existing sites in a bid to boost efficiency.

More on Prestige Brand's FQ3: OTC Healthcare segment revenue up 25.9% Y/Y to $84.9M led by sales of Little Remedies and The Doctor's, while Household Cleaning sales fell off 7.8% to $21.3M. Completes acquisition of 15 of the 17 brands it purchased from GlaxoSmithKline, with 2 set to be completed in H1.

Key players in the pharmaceutical industry pledged on Monday to donate 14 billion drug treatments as part of a new, global push to eradicate tropical diseases.

News from Europe's pharmaceutical manufacturing industry coupled with upcoming events, and exclusive articles and interviews from industry experts.

Sanofi's fourth quarter income of Genzyme and emerging markets offsets the death of patents and the effect of European Union rigor.

There are relatively few drug companies that offer a truly balanced opportunity for investors.

Medivir AB 's Partner GlaxoSmithKline Initiates OTC Launch of Xerclear in Europe Under Trade Names Zoviduo and Zovirax Duo Medivir AB , the research-based specialty pharmaceutical company focused on infectious diseases, announces that its unique cold sore product XerclearA , which Medivir developed in-house, is now being launched for ... (more)

GSK is developing tablets it can compress without excipients to cut the time taken to reach the clinic by up to nine months.

GlaxoSmithKline released fourth-quarter 2011 and full-year financial results Tuesday, which happens to be Charles Dickens' birthday.